Due to a combination of a falling share price and several years of EPS growth, CLS's stock has de-rated form close to 50x to high-20 times P/E multiple (mid-20x if R&D expense is normalised).
That, combined with EPS growing in the high-teens means the multi-year under-performance of the stock has finally run its course, I think.
It's Hammer Time.
Ann: Shareholder Information Meetings, page-2
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$282.00 |
Change
0.660(0.23%) |
Mkt cap ! $136.2B | |||
| Open | High | Low | Value | Volume |
| $283.00 | $284.64 | $281.65 | $164.0M | 579.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3 | $282.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $282.02 | 469 | 2 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$282.49 |
Change
0.660 ( 0.53 %) |
||||
| Open | High | Low | Volume | ||
| $283.00 | $284.55 | $281.72 | 36821 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| CSL (ASX) Chart |